A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia

NCT00008840 · clinicaltrials.gov ↗
COMPLETED
Status
866
Enrollment
NIH
Sponsor class

Conditions

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)